Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

South Korea Pharma Report

May 2009

News

  • No News

Top Story

17.06.2015

South Korea : Korea: Can High R&D Spending Lead To Commercial Success?

Local flagship company Boryung has found success with its newly developed angiotension receptor blocker (ARB) Kanarb. Nine molecules currently exist worldwide in this category of antihypertensives, and Kanarb is currently ranked eighth. “Boryung is the only domestic company that has …

view more

snapshot in figures

Clinical trials in South Korea

  • Associations view more
  • Interviews

    16.06.2015

    Interview: Jung Hyun Ho – Founder & CEO, Medytox – Korea

    Medytox is the most valuable pharmaceutical business in Korea, with a highly successful botulinum toxin product on the market, and can only grow further when they finish development of their second generation botulinum toxin product that will be commercialized globally …

    view more

    Most Read


    X
    Download PDF

    First Name:

    Last Name:

    Company:

    Position:

    Country:

    Email: